Taurine (relaxation).

Taurine is a weak agonist at GABA-A receptors as well as at glycine receptors, opening the same inhibitory chloride current GABA acts on. The two work on one settled receptor family.

Both taurine and glycine are agonists at the strychnine-sensitive glycine receptor, the main fast inhibitory channel in brainstem and spinal circuits. Their calming effect on excitability shares one mechanism.

Theanine is a glutamate analogue that modulates glutamatergic signalling and raises alpha activity, while taurine works on the inhibitory chloride side. They lower excitatory tone from opposite directions.

Magnesium blocks the NMDA channel pore and the glycinate carrier delivers glycine, which acts at the same inhibitory receptor taurine occupies. All three parts of the pairing push excitability in one direction.

Magnesium restrains calcium entry and NMDA channel opening while taurine stabilises membrane potential as an intracellular counter-ion. Magnesium taurate is the long-standing single-salt expression of the pair.

Pyridoxal-5-phosphate is the cofactor for both cysteine sulfinate decarboxylase, which makes taurine, and glutamate decarboxylase, which makes GABA. One vitamin gates both inhibitory pathways in this pairing.

Beta-alanine and taurine compete for TauT uptake, so a large beta-alanine dose lowers tissue taurine including in nervous tissue. Anyone stacking a buffering product with a calming one should know the two pull on one transporter.

Endogenous taurine is built from cysteine: cysteine dioxygenase makes cysteine sulfinic acid, which is decarboxylated to hypotaurine and then oxidised to taurine. Cysteine supply is the rate-limiting input to that chain. This says where taurine comes from, not that added cysteine raises taurine levels in a person already taking taurine.

Methionine feeds the transsulfuration pathway that produces cysteine, which is the direct precursor of taurine. So methionine sits two steps upstream of endogenous taurine synthesis. The relationship is metabolic accounting rather than a supplement pairing with combination data.

Sulfite oxidase, which handles the sulfite arm of sulfur amino acid breakdown, needs a molybdenum cofactor. Taurine synthesis draws on the same cysteine pool that feeds that branch. The connection is a settled cofactor relationship in sulfur metabolism.

N-acetylcysteine is deacetylated to cysteine, the substrate that cysteine dioxygenase commits toward taurine. Most of that cysteine goes to glutathione first, so the share reaching taurine is modest. Read this as a shared upstream pool rather than a way to raise taurine.

Taurine is one of the two amino acids the liver conjugates onto bile acids, producing taurocholate and its relatives. Conjugation keeps bile acids ionised and water soluble across the pH range of the small intestine. That is textbook physiology and explains why bile acid literature and taurine literature overlap so heavily.

Taurine-conjugated bile acids are part of how dietary long-chain fats are emulsified and taken up as mixed micelles. Anything that supports normal bile acid conjugation sits upstream of fat handling. The pairing is mechanistic. No combination trial is cited here.

Taurine is one of the major free intracellular osmolytes, and cells move it in and out through the TauT transporter to hold volume steady as ion gradients shift. Potassium is the dominant intracellular cation setting those gradients. The two are therefore linked through cell volume regulation rather than through a shared receptor.

The TauT transporter carries taurine into cells against its gradient using the sodium gradient as the energy source, with a fixed sodium and chloride stoichiometry. Cellular taurine uptake is therefore sodium dependent by design. High extracellular taurine also down-regulates the transporter, which is why loading is self-limiting.

Taurine holds intracellular osmolality while sodium, potassium, chloride and magnesium set the extracellular side, so the two act on opposite faces of the same balance. This is why taurine turns up in hydration formulas. It is a formulation rationale grounded in transport physiology, not a measured hydration outcome.

Taurine and caffeine are combined in most energy products, and much of the human taurine literature is actually literature on that combination. Caffeine is an adenosine receptor antagonist while taurine acts as a low-affinity agonist at inhibitory chloride channels, so the two pull in opposite directions on arousal. Any study of the pair cannot separate their contributions.

Taurine has weak agonist activity at GABA-A and glycine receptors, both inhibitory chloride channels, while melatonin acts through its own MT1 and MT2 receptors on circadian timing. Stacking them is plausible on paper and common in evening formulas. No trial of the combination is cited here, so treatment of this as additive is inference.

Valerian constituents interact with the GABA-A complex and taurine is a weak agonist at the same channel family. Combining two agents acting on the same inhibitory channel can add up more than either alone. Regard this as mechanistic overlap worth flagging rather than a demonstrated combined effect.

Apigenin, the chamomile constituent most studied for calm, binds the benzodiazepine site of the GABA-A receptor. Taurine acts at a different site on the same receptor family. The overlap is on the same channel, so the pairing is worth naming even without combination data.

Apigenin is a benzodiazepine-site ligand at GABA-A, and taurine is a low-affinity direct agonist at the same receptor class. Two agents touching one receptor complex through different sites are the classic setup for an additive response. Nothing here is measured in humans taking both.

Lemon balm constituents have been described as inhibiting GABA transaminase, which raises local GABA availability, while taurine acts on the receptor side. The two therefore approach the same inhibitory tone from different ends. Evidence for the pairing itself is not established.

Passionflower flavonoids are described as GABA-A modulators, the same receptor family taurine touches weakly. Evening formulas commonly stack them. Read the pairing as mechanistic overlap, not as a tested combination.

Inositol and taurine are both organic osmolytes that brain cells accumulate to hold volume under osmotic stress, and they are regulated in parallel. That shared role is why they appear together in osmolyte panels. It is a shared physiological category, not a demonstrated combined effect on mood or calm.

Retinal tissue concentrates both taurine and zinc, and zinc modulates several inhibitory chloride channels that taurine also acts on. The two therefore co-occur in the same tissue chemistry. This is a mechanistic observation, not evidence for taking them together.

5-HTP is decarboxylated to serotonin and onward to melatonin, acting on the monoamine side of evening physiology, while taurine works on inhibitory chloride channels. The two routes converge on the same downstream state without sharing a target. The pairing is formulation logic and carries no combination evidence here.